Navigation Links
Halozyme Therapeutics' Enhanze Technology Large Protein Molecule,Therapeutic Clinical Trial Results Presented at the 34th Annual,Meeting of the Controlled Release Society

hyaluronidase as an adjuvant to increase the absorption and dispersion of co-injected small molecule drugs, to Halozyme's knowledge, this was the first clinical trial conducted to support the benefits and safety of rHuPH20 for use with large molecule agents, such as monoclonal antibodies and other large molecule biologics. Most therapeutic antibodies are 60% to 70% systemically bioavailable following SC injection, allowing room for improvement in absorption. Other therapeutic large molecule agents have even lower systemic bioavailability, and still other agents may not be developed for SC administration because of low systemic bioavailability through this route of administration. rHuPH20 is the first and only hyaluronidase from a recombinant human source that is FDA-approved, currently in a 150 U product configuration.

"The remarkable findings from this clinical trial, estimating that co-injection of rHuPH20 in high doses can boost the SC absolute bioavailability of an LPMT from 64% to essentially 100%, validates similar findings from animal models," said Richard C. Yocum, MD, Vice President of Clinical Development and Medical Affairs at Halozyme. "We have shown previously in two different animal species and with three different representative large molecules that rHuPH20 locally co-injected with the large molecule increases the bioavailability in a rHuPH20 dose-dependent fashion and to essentially complete absorption."

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing recombinant human enzymes for the drug delivery, palliative care, oncology, and infertility markets. The company's portfolio of products is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. In addition, the company has received FDA approval for two pr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
7. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
8. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
9. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
10. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
11. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
Post Your Comments:
(Date:12/24/2014)... 24, 2014  Actavis plc (NYSE: ... received a complete response letter from the U.S. ... Drug Application (NDA) for the fixed-dose combination (FDC) ... hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... the receipt of a complete response letter, Actavis ...
(Date:12/24/2014)... 24, 2014 Kinex Pharmaceuticals announced today that ... Roswell Park Cancer Institute. KX2-361 (KX02), a ... has shown potent inhibitory activity against a broad panel ... resistant to Temozolomide (T98G), the most widely used chemotherapy ... brain tumor mouse model, KX2-361 consistently clears brain tumors ...
(Date:12/24/2014)... Dec. 24, 2014  Conkwest, Inc., the Natural ... proprietary Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) ... Patrick Soon-Shiong , NantWorks founder, physician scientist and ... to purchase approximately $48 million of the Company,s ... investment, he will be named Co-Chairman of the ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5
(Date:12/25/2014)... 26, 2014 Recently, Dylan Queen, a ... excitedly released its collection of discounted prom dresses, most ... a senior spokesman of the company, the promotion is ... promotion is to expand the UK market. , The ... different colors, lengths, and styles: A-line strapless, empire strapless ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... The risk of burns from fires and cooking accidents ... extra cautious, an expert says. "Between Thanksgiving and ... patients coming in with burns," said Dr. Steven Sandoval, ... Center of Stony Brook University Hospital in New York. ... if not careful, could quickly turn tragic," Sandoval said ...
(Date:12/25/2014)... tries its best to translate the experience of dress ... introduced its new collection of 2015 prom dresses, and ... prom outfits are guaranteed to contain the perfect designs ... designed for 2015. Anyone who wants to buy ... before Jan. 26, 2015, the deadline of the promotion. ...
(Date:12/25/2014)... December 25, 2014 Residents at ... Community, recently showed their generous spirit by providing ... Catawba County Parenting Network- Grandparents Raising Grandchildren program. ... gathered around the largest Christmas tree on the ... purchased by residents of the Abernethy Village Association ...
Breaking Medicine News(10 mins):Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:Don't Let Burns Mar Your Holidays 2Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... the air, indeed! Today, it has been revealed that deaths ... past decade// and we owe this development to better ... treatment measures. ,The data enabled by the government ... deaths since 1966 for those below 75 years of age. ...
... women with higher levels of Vitamin-E in their blood are ... ,Theresa O. Scholl and colleagues at the University of ... women and measured the plasma concentrations of alpha-tocopherol-one, a form ... pregnancy. ,They found the women who had ...
... Delhi Chief Minister Sheila Dikshit today inaugurated a new 120-bed ... at the Tihar Jail//, one of Asia’s biggest prisons having ... the jail hospital premises, was built at a cost of ... of its kind to be started in any jail in ...
... A team of University of California, San Diego physicists ... of blood vessels// in the brain that makes it ... of the puzzling damage to the brain’s gray matter ... ,In the study, published this week in the ...
... of us think of chromium as the shiny metal in ... the metal plays a crucial role in human health//, reports ... In rats, chromium deficiency leads to high cholesterol levels. In ... information, it’s too early to recommend chromium supplements for cholesterol. ...
... it’s our most vital organ, surprisingly little is ... makes it harder to uncover what’s gone awry ... brain-associated disorders, and ultimately, it often leaves physicians ... as Alzheimer’s and Parkinson’s disease, schizophrenia, attention deficit ...
Cached Medicine News:Health News:Bottleneck in Blood Supply Makes Brain Vulnerable to Strokes 2Health News:Bottleneck in Blood Supply Makes Brain Vulnerable to Strokes 3Health News:Chromium May Help Diabetes, Cholesterol, and Heart Disease 2Health News:Researchers Looking for Genes That Control the Brain 2
Overall length 355 mm, 14.0 inches....
Achievement, available exclusively from Art Optical, is a unique RGP lens design with a patented junctionless back surface and a controlled edge lift....
... of the Polycon II lens design with ... The result is a thin lens that ... surface characteristics, durability and superior oxygen delivery. ... service and expedited delivery, Artcon is the ...
Boston Multivision design is manufactured in Boston ES material for early presbyope patients. Boston Multivision lens provides crisp, clear vision at near, intermediate, and far distances and excelle...
Medicine Products: